- New look, same great product!
- Highly absorbed Curcugreen extract*
- 95% curcuminoids
- Fish-based softgels
- 120-ct. (60-servings)
- NSF-Tested & certified
- 500mg curcumin + 245mg omega-3s per serving
- MSC certified wild Alaskan sockeye salmon oil
- No artificial preservatives or colors
- No oxalates
- Product of USA
*Absorbed 7-9 times better than standard curcumin extracts.
Turmeric grows wild in the forests of South and Southeast Asia, and is cultivated for culinary and medicinal use. It's a key ingredient in the yellow-orange curry spice blends used in many Indian, Persian, Thai, Chinese, and Indonesian dishes.
The ancient Indian medicine tradition known as Ayurveda has long featured turmeric in healing*.
The orange-yellow "curcuminoid" compounds that give turmeric its rich hue are believed responsible for the root's potential health benefits*.
Researchers use the term "curcumin" in reference to three specific curcuminoids, which appear largely responsible for its beneficial effects.
Together with modern epidemiological evidence from India, where turmeric root and turmeric-rich curries are dietary staples, its ancient healing tradition has triggered extensive research into the possible health-promoting properties of curcumin. (To learn more, click here.)
Among other things, curcumin appears to exert beneficial effects on gene switches affecting inflammation, which is a factor in many degenerative processes*.
The Vital Choice Curcumin advantage
In its "raw" form, curcumin is very poorly absorbed.
Thankfully, clinical studies show that the curcumin extract we use - Curcugreen - is absorbed 7 to 9 times better than curcumin in conventional supplements (Antony B et al. 2008).
This advantage means that one 500mg serving (two softgels) of Vital Choice Curcumin is equivalent to about 3,000mg of a typical curcumin supplement.
And curcumin is absorbed much better when it's consumed along with fats, so we mix it into Vital Choice Wild Alaskan Sockeye Salmon Oil, which provides beneficial omega-3s fatty acids (Goindi S et al. 2010; Jäger R et al. 2014).
The Curcugreen extract includes turmeric's volatile compounds (e.g., turmerones, curcumenes, zingerbene), which enhance the absorption of curcumin, and provide benefits of their own.
Last but not least, the Indian firm that makes our curcumin extract is widely recognized for its pioneering "green" practices (see their video at YouTube).
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Curcumin cautions and drug interactions
- Dietary turmeric may inhibit the anti-tumor action of chemotherapeutic agents such as cyclophosphamide.
- Curcumin may interact with drugs that are substrates of P-glycoprotein (P-gp) or cytochrome P450 enzymes.
- The oxalates in turmeric promote formation of kidney stones, but these compounds are virtually absent from curcumin.
- Curcumin prevents gallstone and kidney stone formation in rodents, but promotes contraction of the gallbladder, which could exacerbate gallstone problems in human patients. People with bile duct obstruction, gallstones, or GI disorders, including stomach ulcers and hyperacidity disorders, should consult a physisican before taking this supplement.
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007 Nov-Dec;4(6):807-18. Epub 2007 Nov 14. Review.
- Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), A novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
- Antony B, Merina B, Rao SB. Enhancing the absorption of curcuminoids. Spice Board of India. July 2005, 23-26.
- Antony B, Merina B. Bioavailability of Curcumax (BCM – 095). Little Flower Medical Research Center, Angamaly, India (Research Center of Mahatma Gandhi University). September 2006. Spice Board of India.
- Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011 Apr 25;74(4):664-9. doi: 10.1021/np1007262. Epub 2011 Mar 17.
- Garcea G, Jones DJ, Singh R, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 2004; 90: 1011-1015.
- Ghodasara J, Pawar A, Deshmukh C, Kuchekar B Inhibitory effect of rutin and curcumin on experimentally-induced calcium oxalate urolithiasis in rats. Pharmacognosy Res. 2010 Nov;2(6):388-92. doi: 10.4103/0974-8490.75462.
- Goindi S. Comparative bioavailability of curcumin, turmeric and Biocurcumax in traditional vehicles using non-everted rat intestinal sac model. Journal of Functional Foods. 2010; 2(1):60-65. https://doi.org/10.1016/j.jff.2010.01.004curcumin
- Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nutr J. 2014 Jan 24;13:11. doi: 10.1186/1475-2891-13-11.
- Li Y, Li M, Wu S, Tian Y. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process? Lipids Health Dis. 2015 Sep 3;14:100. doi: 10.1186/s12944-015-0106-2.
- Rasyid A, Rahman AR, Jaalam K, Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002;11(4):314-8.
- Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. 1999 Feb;13(2):245-9.
- Shubha MC, Reddy RR, Srinivasan K. Antilithogenic influence of dietary capsaicin and curcumin during experimental induction of cholesterol gallstone in mice. Appl Physiol Nutr Metab. 2011 Apr;36(2):201-9. doi: 10.1139/h10-102.
- US Patent No: US 7,736,679 B2.
- Volak LP, Ghirmai S, Cashman JR, Court MH. Curcuminoids inhibit multiple human cytochromes P450 (CYP), UDP-glucuronosyltransferase (UGT), and sulfotransferase (SULT) enzymes, while piperine is a relatively selective CYP3A4 inhibitor. Drug Met. Disp. 2008;36(8), 1594–1605.
- Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol. 2012 Mar;69(3):679-89. doi: 10.1007/s00280-011-1749-y. Epub 2011 Oct 4.